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Abstract 
We have isolated the murine gene encoding the 5-HT, receptor (5-HT,R), a member of the ligand-gated Ion channels, that mediates a variety of 
physiologtcal effects in central and peripheral neurons. DNA sequence analysis of the 5-KT,R gene revealed its organisation in 9 exons distributed 
over approximately 12 kbp of DNA. Alternative use of exon 9 splice acceptor sites generated two .5-HT,R variants. The S-HT,R gene, whose structure 
is closely related to neuronal and muscle AChRa genes, as demonstrated by four common splice junctions, was locahsed on human chromo- 
some 11. 
Key ~rw-d~: Serotonin; Gene structure: Alternative splicing; Mouse brain; Exon alignment 
1. Introduction 
5-Hydroxytryptamin (5-HT), a neurotransmitter in- 
volved in various physiological functions exerts its ef- 
fects by binding to a variety of neuroreceptors. In con- 
trast to the G-protein coupled serotonin receptors, the 
5-HT, receptor (5-HT3R) belongs to the family of tigand- 
sated ion channels [1,2]. The 5-HT, receptor is widely 
distributed in the peripheral [3] and central nervous sys- 
tem (CNS) [4,5] and is believed to play an important role 
in anxiety [6], cytotoxic drug evoked emesis [7]. nocicep- 
tion [8] and may contribute to psychiatric disorders [9]. 
Recently a cDNA coding for a 5-HT,R subunit was 
isolated from the mouse cell line NCB-20 by means of 
expression cloning [IO]. The deduced 5-HT,R protein 
revealed many structural characteristics common to 
other members of the ligand-gated ion channel superfa- 
mily, including four putative transmembrane regions 
(TM 1 -TM4), a cystein loop and a large intracellular loop 
separating TM3 and TM4. Pha~acologicai and physio- 
logical data have suggested the presence of interspecies 
variation of the 5-HT,R, but no receptor variability 
within a species [l l-15) which is in contrast to other 
members of the ligand-gated ion channel superfamily 
[16-191. In this report we describe the isolation and se- 
quencing of genomic DNA carrying the murine 5-HT3R 
gene as a first step to examine mechanisms generating 
variable 5-HT3R transcripts and to analyse the efficacy 
of DNA sequences in regulation of the 5-HT3R gene 
activity. Moreover, the chromosomal ocalisation of the 
human homologue of the mouse 5-HT,R gene was inves- 
tigated. 
2. Materials and methods 
2.1. Screening of hhruries 
A 5-HT,R cDNA clone was isolated by screening a mouse brain 
cDNA library constructed in &ZAP11 (gift of K. Nave) using the 
end-labelled synthetic oligonucleotides SHT7as (Y-GTCCCTTGCC- 
ACCTCCCGCATCTCATCCCGCTTCTCCAGGAAGTGGCGGA- 
T-3’) and 5HTSas (S-CTGAACTTCACCTCGATGATGCACGTA- 
CACATAAGGAATGTTCGGAGA-3’) corresponding to the NCB-20 
derived cDNA sequence position 1360-1410 and 463--510 taken from 
the EMBL data library (Accession No. M74425) [lo]. Recombinant 
&phages carrying the mouse S-HT,R gene were Isolated by screening 
5 x IO’ PFU of a genomic DNA library constructed in R-Fix 1201 using 
the same oligonucleotides. Hybridisation was carrred out at reduced 
stringency (35% formamide: 5 x SSC; 5 x Denhardt’s olution; 20 mM 
Na-phosphate. pH 7.0: lOOpug sonicated salmon sperm DNA/ml) over 
night at 42°C and filters were washed subsequently in 5 x SSC; 
2 x SSC; 1 x SSC (30 min each) at 45°C [21] and exposed to X-ray film 
(Amersham) overnight at -70°C. 
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-7 2 Nucleotide sequence analysis 
The nucleotide sequence of the mouse 5-HT,R gene has been submitted 
to the EMBLlGene bank under Accession No: Z 22772 and Z 22773 
Plasmids carrying the cDNA were excised from the recombinant 
a-Zap11 phages according to Stratagenes protocol and additional de- 
leted subclones useful in DNA sequence analysis were selected after 
plasmid preparation and restriction analysis on agarose gels. Similarity, 
overlapping restriclton fragments of genomic DNA from recombinant 
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d-Fix phages were clones in pBKS (Stratagene). DNA sequence analy- 
SIS by the dideoxynucleotide chain termination method [22] was per- 
formed using the Sequenase kit version 2.0 (United States Biochemical 
Corporation) following the conditions recommended by the supplier. 
2.3. Functional expression of 5-HT,R in Oocytes 
A S-HT,R cDNA fragment of 1546 bp was amplified by PCR [23] using 
a sense primer (5HT,R-ATG: Y-CTCTCTAGATCTGCCAC- 
CATGCGGCTCTGCATCCCGCAGGTG-3’) covering the transla- 
tioxstart site (underlined) and an antisense primer (5-HT,-TER: 
S-TCTCTCAGATCTAGTTCCATAGCCCCTCCCTGCC-3’) local- 
ized 35 nucleotides downstream of the translation termination codon. 
Furthermore, to increase translational efficiency of the in vitro syn- 
thesised mRNA. the translation start site CTTGCCATG was renlaced 
by GCCACCATG which is more related to the Kozak consensus e- 
quence [24]. PCR was performed in 50~1 using 10 ng of the supercoiled 
cDNA clone and 15 cycles of 1 min at 94’C, 1 min at 37°C and 1.5 min 
at 72°C were sufficient to amplify the cDNA fragment according to 
[25]. The PCR product was digested with BgnI, purified and cloned into 
the Bgll1 site of pSPOoD a derivativ of pSP64T [26,27]. Site-directed 
mutagenesis [25,28] was performed to replace amino acid differences of 
the extracellular N-terminal region corresponding to the NCB-20 cell 
line derived cDNA [lo]. Finally, two differences remained, an addi- 
tional alanine between TM2 and TM3 and a deletion of 6 amino acids 
(aa) within the large cytoplasmic loop [29]. To evaluate the relative 
contribution of these 6 aa to 5-HT,R behaviour a receptor carrying 
these 6 aa was constructed. Specific mRNAs were synthesized from SalI 
lmearized plasmids in vitro with SP6-RNA polymerase (Promega). 
Xenopus laevis oocytes were injected with mRNA of a single 5-HT,R 
variant and incubated for 2-5 days at 19°C [27]. The channel expression 
was determined by measuring the whole-cell current ehcted in response 
to 3 PM 5-HT in normal frog Ringer solution and membrane potential 
held at -30mV. 
2.4 Chromosomal mappmg 
DNA for genomic Southerns was prepared from cell lines, according 
to standard techniques. Aliquots (10 pg) of genomic DNA were di- 
gested with EcoRI, electrophoresed on 0.8% agarose gels, and trans- 
ferred onto nylon membranes (GeneScreen, NEN) followed by UV 
crosslinking. GeneScreen filters were prehybridised and hybridised in 
0.5 M NaPi; pH 7.2; 7% SDS; 1 mM EDTA at 65’C. essentially as 
described [30]. Hybridisation probes were radiolabeled to a specific 
activity of 1 x 10’ cpm@g by random priming and included in hybrid- 
isation at 2 x IO’ cpm/ml. After hybridisation, filters were washed ex- 
tensively in 40 mM NaPi, 1% SDS at 65°C prior to autoradiography. 
3. Results 
3.1. Isolation of a mouse brain S-HT,R cDNA 
In order to characterise the 5-HT,R gene, we initially 
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cloned a mouse brain 5-HTXR cDNA. For this purpose, 
a cDNA library was screened with the synthetic oligonu- 
cleotides 5HT7as and 5HT8as. Among IO6 plaques one 
hybridizable recombinant phage was isolated and char- 
acterised by DNA sequence analysis. The mouse brain 
5-HT,R cDNA sequence resembled - with the exception 
of a 51 nucleotide (nt) extension at the 5’ end and two 
deletions of 4 bp and 5 bp apparently produced by er- 
roneus splicing at the junctions of exonl/2 and 516 - the 
cDNA sequence of the NlE-115 clone [29] (data not 
shown). Both cDNA’s represent a 5-HT3R variant, 
where, in contrast to the NCB-20 cDNA [IO], 18 nucleo- 
tides encoding 6 aa (GSDLLP) of the large cytoplasmic 
loop have been deleted. Similarily, the same deletion of 
18 bp was identified in a rat brain 5-HT,R cDNA (data 
not shown). 
3.2. Organisation of the mouse 5-HT,R gene 
Functional characterisation of 5-HT, receptors in dif- 
ferent tissues and species [11,121 have suggested the exis- 
tence of various 5-HT,R subtypes. To characterise the 
mammalian 5-HT3R gene in more detail, a mouse 
genomic library constructed in A-Fix [20] was screened 
with oligonucleotides 5HT7as and 5HT8as and two hy- 
bridizing recombinant phages i12141 and L2161 were iso- 
lated. Extensive digestion of the cloned genomic DNAs 
with different restriction enzymes revealed the identity of 
both recombinant clones. Hybridization experiments 
with 5-HT3R cDNA fragments howed that phage A.2141 
contained all coding sequences. Subsequent efforts were 
made to isolate overlapping clones spanning the com- 
plete coding region. However, during subcloning the 
XbaI DNA fragment carrying exon 5 and intron 5 (Fig. 
1) parts of the intron sequences were repeatably deleted 
and nearly 1 kbp of intron 5 is lacking in the submitted 
genomic DNA sequence. The order of the overlapping 
DNA fragments was determined by hybridisation with 
cDNA fragments, and DNA sequence analysis was per- 
formed using the Sequenase system (USB). The mouse 
5-HT,R gene as defined herein is distributed over an area 
E5 E6 E7,8 E9 
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Fig. 1. The 5-HT,R encoding region is distributed over an area of 12 kbp of DNA and organized in 9 exons numbered at the top (El to E9). The 
position of alternative splicing is indicated by an arrow. The mRNA is shown in 5’ to 3’ orientation subdivided by the exon borders. Vertical stripes 
in exon 1 and 9 indicate the 5’- and 3’-untranslated regions whereas the transmembrane segments are attributed by striped boxes in exon 7 (TMl, 
TM2). exon 8 (TM3) and exon 9 (TM4). Restriction endonuclease sites are indicated: X, XbaI; P, PstI. An asterisk indicates the XbaI site (intron 
4) that overlaps with a methylation site (Dam). 
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of 12 kbp of DNA (Fig. 1) and organized in 9 exons 
whose size are shown to range from 45 bp to 829 bp (Fig. 
2). All splice junctions of the mouse 5-HT,R gene are in 
agreement with the consensus equence identified in ver- 
tebrates [31] and exon sequences and exon-intron bor- 
ders are shown in Fig. 2. Alternative splicing of the 
mouse 5-HT,R gene, which is obviously restricted to 
exon 9, deletes 18 bp by alternative use of splice acceptor 
signals (Fig. 2). In mouse brain as well as in mouse cell 
lines [10,29], two 5-HT,R variants appear that differ in 
6 aa of the large cytoplasmic loop. Northern blot analy- 
Fig. 2. The genomic sequence ncoding the murine 5-HT,R together 
with the deduced polypeptide sequence is shown in the one-letter code. 
Coding sequences are given in upper-case letters, the size of the mtrons 
(in lower-case letters) is indicated within the intronic gaps. Alternative 
spliced nucleotldes are shown in bold letters, the transmembrane seg- 
ments are underlined whereas the nucleotldes lacking in the mouse 
brain cDNA are marked by a dotted line. 
23s 
16s 
Fig. 3. Northern blot analysis with mouse brain poly(A)‘RNA (IOpg) 
was performed as described [48]. The complete 5-HT,R cDNA (specific 
activity of 1 x lo9 cpm&g) was used as probe and a single transcript of 
about 2.5 kbp was determined. The filter was exposed to X-ray film for 
8 day at -70°C. Arrows indicate the positions of the E. co/i ribosomal 
RNA’s 16 S and 23 S. 
sis of mouse brain mRNA revealed a single low abun- 
dant 5-HT,R transcript of about 2500 bp (Fig. 3). 
3.3. Oocyte expression 
To determine the importance of the 6 aa encoded by 
the alternatively spliced 18 nucleotides of exon 9, whole 
cell recordings of Xenopus laevis oocytes injected with 
RNA’s of either of the variants were measured in the 
two-electrode voltage clamp configuration (27). Both 5- 
HT3R variants elicited similar signals in response to 
3 ,uM serotonin in normal frog Ringer’s solution and are 
blocked by 3 nM o-Turbocurarine in similar way which 
suggests that channel properties are unaffected by these 
6 aa (data not shown). 
3.4. Alignment of the S-HT,R gene with neuronal and 
muscle AChRu genes 
The mouse 5-HT3R gene intron+xon organisation 
showed striking similarities to muscular and neuronal 
nicotinic AChR genes [32-361, but is unrelated to other 
members of the ligand-gated ion channel family [20,37]. 
The exon-intron positions are compared with respect o 
the common structural features of the ligand-gated ion 
channel proteins, particularily the disulfide structure and 
the putative membrane spanning segments. The mouse 
5-HT,R cDNA revealed an overall homology of 45.9% 
with the chicken AChRa7 receptor sequence [32] corre- 
sponding to about 30% homology on protein level. In the 
mouse 5-HT,R gene, as in the chicken genes AChRa7 
[32] and AChRa [33], in the human and calf AChRa 
genes [34], and in the rat AChw4 gene [35] introns 2, 3 
and 4 show identical positions and exon 3 (45 bp) as well 
as exon 4 (110 bp) show identical size. Furthermore, 
exon 3 encodes a considerably conserved peptide domain 
with striking homology to the corresponding region of 
neuronal and muscular AChR’s [32-361 (chicken 
AChRa7 = 73.3%, chicken AChR a4 = 60%, chicken 
AChR a2 = 53%; rat AChR a2, 4, 5 = 60%, rat AChR 
a3, 84 = 46,6% and chicken AChr 01 = 46%, calf and 
human AChR a = 40%) and conservation is extended 
into exon 4 encoded sequences with peptide homologies 
of 48% = chicken AChRa and a2; 43% = rat AChRa2; 
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40% = chicken AChRa7 and a4; 38% = human AChRa; 
32% = chicken AChRa3 and rat AChR/J4 132-361. Out- 
side this region, only the cystein loop (60%) and the 
transmembrane segment TM2 (42%) showed an elevated 
level of homology compared to chicken ACha7 [32]. In 
addition, the splice acceptor position of exon 8 is con- 
served in chicken AChRa7, but not in other AChRa 
genes. 
The localisation of the mouse 5-HT, receptor gene 
homologue on human chromosomes was determined by 
Southern analysis of DNA isolated from 39 different 
rodent-human hybrid cell lines. Filter with DNA of 
these cell lines containing defined overlapping subsets of 
5-16 human chromosomes and 24 cell lines represent 
monochromosomal hybrids (NIGMS mapping panel #l 
and #2 1381). Chromosomal DNA from hybrid cells and 
parental ines were digested with EcoRI and examined by 
Southern analysis. The 5-HT3R cDNA probe consis- 
tently revealed a hyb~dising human signal of 3.0 kbp in 
all cell lines containing chromosome 11 (GM~A9934, 
GM~AO9936, GM~AO9938, GM~AlO927A, data 
not shown) and was easily distinguishable from the ham- 
ster and mouse signals, thus providing clear evidence 
that 5-HT3R maps to human chromosome11 (data not 
shown). 
4, Discussion 
The results presented here provide the first description 
of the mouse gene encoding the 5-HT, receptor. A re- 
combinant ;l-phage (22141) carrying the complete cod- 
ing region of the mouse 5-HT3R was isolated and char- 
acterised by DNA sequence analysis. The mouse 5-HT3R 
gene is organized in 9 exons spanning an area of approx- 
imately 12 kbp of DNA (Fig. 1). A remarkable structural 
conservation of exon 3 and exon 4 is observed in the 
mouse S-HT,R gene as well as in neuronal and muscular 
AChRa and 84 genes [32-361, but is absent in other 
ligand-gated ion channel encoding genes [20,37]. More- 
over, exon 3 encoded amino acids are highly conserved 
between mouse 5-HT,R gene and muscle and neuronal 
AChRa and AChR/?4 subunit genes 132-363, suggesting 
a possible similarity between the tertiary and quaternary 
structure of the agonist-antagonist binding domain of 
these receptors [39,40]. 
Functional diversity of ligand-gated ion channels is 
mainly generated by alternative splicing and variable 
combination of subunits [19,41]. For example, glutamate 
receptors exist in flip and flop versions which encode 
slightly different peptides of 38 amino acids (19,41). The 
presence of these exons (flip or flop) coincide with differ- 
ent pha~acological properties and different distribu- 
tion in the ma~alian brain [41]. Similarily, an alterna- 
tive exon encoding 8 aa of the homologous region of the 
GABA-Ay2 receptor subunit has been proposed to de- 
termine ethanol sensitivity in these receptors [42]. Such 
differences, however, are not observed for the 5-HT,R 
gene, where, similar to the GABA-A-/34 [37] and the 
ACha5 subunit gene [35], receptor variants are generated 
by variable use of splice donor or acceptor signals. In 
mouse brain and mouse cell lines [10,29] two 5-HT3R 
variants appeare by alternative use of two splice acceptor 
signals of exon 9 which remove 6 aa of the large cytoplas- 
mic loop, however, whole cell currents revealed no differ- 
ence in sensitivity to n-Turbocurarine between the 5- 
HT,R and the splice variant lacking these 6 aa. T-PCR 
detected both 5-HT,R variants in the mouse brain, but 
the variant lacking the 6 aa is seemingly predominant 
indicating a possible role of these amino acids in receptor 
distribution. 
Using a series of somatic hybrids cell lines, we have 
localised the human homolog of the mouse 5-HT3 recep- 
tor gene on human chromosome 11. The mapping of 
5-HT,R to chromosome 11 is interesting for a number 
of reasons. Recently, several families have been de- 
scribed where schizophrenia nd manic depression segre- 
gate thighly with cytogenetic abnormalies involving ei- 
ther the short or the long arm of chromosome 11 1431171. 
In one of these families with schizophrenia, the observed 
translocation point involves a balanced t( 11;l) transloca- 
tion, which has been shown to reside between two genetic 
markers on llq14-q21 [45]. Another family with manic 
depression carried a translocation t(9;ll) on 1 lq22.3 1461. 
Positive linkage findings to maniac depression on 11 ~15 
have also been reported [47]. Treatment of mental disor- 
ders with .5-HT,R antagonists has been suggested to af- 
fect the course of the disease, e.g. in schizophrenia [9], 
This potential correlation renders S-HT,R as an interest- 
ing candidate locus for linkage studies in major psychia- 
tric disorders. Sublocalisation, e.g., by in situ hybridisa- 
tion, of the 5-HT,R sequence to either one of the mental 
disorder candidate regions on human chromosome 11 
could be used to determine if defects in the human ho- 
molog of the mouse 5-HT,R gene underly certain of the 
mental genetic disorders in man. 
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